The Moderna Vaccine IndexThese companies are selected for composition "Moderna Vaccine" because
1.developed the vaccine
2.suppliers
3.distribution chain
Weights are calculated by relative market cap.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.20EUR
170.34 MEUR
829.51 MEUR
17.95 M
About LABORATORIOS FARMACEUTICOS ROVI S.A.
Sector
CEO
Juan López-Belmonte Encina
Headquarters
Madrid
Website
Employees (FY)
2.11 K
Founded
1946
ISIN
ES0157261019
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ROVI is 82.45 EUR — it has decreased by 2.37% in the past 24 hours. Watch LABORATORIOS FARMACEUTICOS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange LABORATORIOS FARMACEUTICOS stocks are traded under the ticker ROVI.
LABORATORIOS FARMACEUTICOS is going to release the next earnings report on Jul 24, 2024. Keep track of upcoming events with our Earnings Calendar.
ROVI stock is 2.43% volatile and has beta coefficient of 0.36. Track LABORATORIOS FARMACEUTICOS stock price on the chart and check out the list of the most volatile stocks — is LABORATORIOS FARMACEUTICOS there?
Yes, you can track LABORATORIOS FARMACEUTICOS financials in yearly and quarterly reports right on TradingView.
ROVI stock has fallen by 0.30% compared to the previous week, the month change is a 1.29% rise, over the last year LABORATORIOS FARMACEUTICOS has showed a 103.78% increase.
ROVI net income for the last quarter is 51.51 M EUR, while the quarter before that showed 52.18 M EUR of net income which accounts for −1.29% change. Track more LABORATORIOS FARMACEUTICOS financial stats to get the full picture.
Today LABORATORIOS FARMACEUTICOS has the market capitalization of 4.33 B, it has increased by 0.18% over the last week.
Yes, ROVI dividends are paid annually. The last dividend per share was 1.05 EUR. As of today, Dividend Yield (TTM)% is 1.25%. Tracking LABORATORIOS FARMACEUTICOS dividends might help you take more informed decisions.
Like other stocks, ROVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIOS FARMACEUTICOS stock right from TradingView charts — choose your broker and connect to your account.
ROVI reached its all-time high on Apr 29, 2024 with the price of 84.65 EUR, and its all-time low was 36.20 EUR and was reached on Jan 16, 2023. View more price dynamics on ROVI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 12, 2024, the company has 2.11 K employees. See our rating of the largest employees — is LABORATORIOS FARMACEUTICOS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATORIOS FARMACEUTICOS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATORIOS FARMACEUTICOS stock shows the sell signal. See more of LABORATORIOS FARMACEUTICOS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LABORATORIOS FARMACEUTICOS future price: according to them, ROVI price has a max estimate of 93.00 EUR and a min estimate of 66.00 EUR. Watch ROVI chart and read a more detailed LABORATORIOS FARMACEUTICOS stock forecast: see what analysts think of LABORATORIOS FARMACEUTICOS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABORATORIOS FARMACEUTICOS EBITDA is 243.80 M EUR, and current EBITDA margin is 29.39%. See more stats in LABORATORIOS FARMACEUTICOS financial statements.